Evidence map›Paper›PMID 25110539›Full record

ArticleJournal of clinical medicine research2014

Effect of statins on endothelial function in patients with acute coronary syndrome: a prospective study using adhesion molecules and flow-mediated dilatation.

Ibrahim Altun, Fahrettin Oz, Selda Can Arkaya, Ilknur Altun, Ahmet Kaya Bilge, Berrin Umman, Umit Mutlu Turkoglu

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical medicine research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Beyond Rejection: Long-Term Survival Following Heart Transplant.Journal of the American Heart Association · 2025
    Article
  4. Review
  5. Review
  6. Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction.Basic & clinical pharmacology & toxicology · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ibrahim AltunDepartment of Cardiology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey.
Fahrettin OzDepartment of Cardiology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey.
Selda Can ArkayaDepartment of Biochemistry, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey.
Ilknur AltunDepartment of Radiology, Sisli Etfal Training and Research Hospital, Sisli-Istanbul, Turkey.
Ahmet Kaya BilgeDepartment of Cardiology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey.
Berrin UmmanDepartment of Cardiology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey.
Umit Mutlu TurkogluDepartment of Biochemistry, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey.
Istanbul University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccumulating evidence suggests that inflammatory mechanisms play a central role in the development, progression and outcome of atherosclerosis. Recent evidence suggests that statins improve anti-inflammatory, anti-thrombotic and endothelial functions, along with their lipid-decreasing effects. We examined the effect of statins on endothelial function using biochemical markers of endothelial dysfunction and brachial artery flow-mediated dilatation (FMD).

methodsThirty male patients presenting with acute coronary syndrome (ACS) and 26 age-matched healthy control subjects aged 40 - 60 years who were not on any medication were enrolled in the study. The patient group was started on atorvastatin (40 mg/day) without consideration of their low-density lipoprotein (LDL)-cholesterol levels. Endothelin, sICAM and E-selectin from stored serum samples were measured using commercially available enzyme-linked immunosorbant assays (ELISAs). Endothelial function was assessed using brachial artery FMD.

resultsPrior to statin treatment, E-selectin, sICAM and endothelin levels, endothelial dysfunction markers, were 99.74 ± 34.67 ng/mL, 568.8 ± 149.0 ng/mL and 0.62 ± 0.33 fmol/mL, respectively in the patient group. E-selectin and sICAM levels were significantly higher in the patients than in the control subjects (P < 0.001); however, endothelin levels were not significantly different between groups. Statin treatment significantly reduced E-selectin and sICAM levels (P < 0.001); however, the decrease in endothelin levels was not statistically significant. %FMD values were significantly increased after statin treatment (P = 0.005), and levels of C-reactive protein (CRP), an inflammation marker, were significantly reduced.

conclusionOur results indicate that statins play an important role in treatment endothelial dysfunction by reducing adhesion of inflammatory cells.

Indexed as

Acute coronary syndromeAdhesion moleculesFlow-mediated dilatationStatinsUltrasonography

Identifiers

PMID25110539
PMCPMC4125330
OpenAlexW1983550834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.